Dr. Mazen Noureddin
Board Member
Book appointment
Dr. Noureddin is the founding Director of Cedars-Sinai’s Fatty Liver Program in Los Angeles, California. His research focuses on the underlying mechanisms of non- alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), new imaging modalities, non-invasive biomarkers, and exploring new treatments. He has conducted several original studies that have been featured in publications in Gastroenterology, Journal of Hepatology, Gut, Hepatology, The American Journal of Gastroenterology, and many others. The Fatty Liver Program at Cedars- Sinai is conducting a number of breakthrough studies and clinical trials targeting new therapies in patients NAFLD and NASH, including those with advanced fibrosis and cirrhosis.
| Specialty | Board Member |
| Work Days | Monday Tuesday Wednesday Thursday Friday Saturday Sunday |
Exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex ea commodo non habent claritatem insitamconsequat duis autem facilisis at vero eros nibh euismod tincidunt.
Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex ea commodo consequat. Duis autem vel eum iriure dolor in hendrerit.